BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6614239)

  • 21. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 22. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet MAO activity in geriatric patients with depression and dementia.
    Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA
    Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the dexamethasone suppression test have clinical utility in psychiatry?
    Baldessarini RJ; Arana GW
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):25-9. PubMed ID: 3968053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z; Arató M; Bagdy G
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early morning awakening in unipolar depressives with higher levels of platelet MAO activity.
    Agren H; Oreland L
    Psychiatry Res; 1982 Oct; 7(2):245-54. PubMed ID: 6183704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood platelet MAO activity in endogenous depressive syndrome].
    Puzyński S; Hauptmann M; Załuska M
    Psychiatr Pol; 1980; 14(6):575-80. PubMed ID: 7232599
    [No Abstract]   [Full Text] [Related]  

  • 30. DST results and platelet MAO activity.
    Hartong EG; Goekoop JG; Pennings EJ; van Kempen GM
    Br J Psychiatry; 1985 Dec; 147():730-1. PubMed ID: 3830339
    [No Abstract]   [Full Text] [Related]  

  • 31. Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity.
    von Knorring L; Perris C; Oreland L; Eisemann M; Eriksson U; Perris H
    J Neural Transm; 1984; 60(1):1-9. PubMed ID: 6207267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatment.
    Moriearty PL; Herrick C; Shafey M; Bornstein P; Becker RE
    Biol Psychiatry; 1987 Sep; 22(9):1155-8. PubMed ID: 3651533
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet monoamine oxidase activity in elderly depressed outpatients.
    Schneider LS; Severson JA; Pollock V; Cowan RP; Sloane RB
    Biol Psychiatry; 1986 Dec; 21(14):1360-4. PubMed ID: 3790624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, endocrine and neurochemical effects of moclobemide in depressed patients.
    Alevizos B; Hatzimanolis J; Markianos M; Stefanis CN
    Acta Psychiatr Scand; 1993 Apr; 87(4):285-90. PubMed ID: 8488751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
    Samson JA; Gudeman JE; Schatzberg AF; Kizuka PP; Orsulak PJ; Cole JO; Schildkraut JJ
    J Psychiatr Res; 1985; 19(4):547-55. PubMed ID: 4078757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B; Sääf J; Wetterberg L
    J Affect Disord; 1995 Oct; 35(1-2):75-87. PubMed ID: 8557890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet MAO activity in patients with chronic pain syndrome. Relationship to personality traits, endorphins in CSF and plasma cortisol.
    Johansson F; Von Knorring L; Oreland L
    Med Biol; 1983 Apr; 61(2):101-4. PubMed ID: 6876894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.